Phoenix Bio

研究発表

研究発表

Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice

    Duehren, S. Uchida, T. Tsuge, M. Hiraga, N. Uprichard, S. L. Etzion, O. Glenn, J. Koh, C. Heller, T. Cotler, S. J. Oka, S. Chayama, K. Dahari, H.
    Virus Res. 2024 Aug 26;349:199451. doi: 10.1016/j.virusres.2024.199451.

    Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response

      Chida, T. Ishida, Y. Morioka, S. Sugahara, G. Han, C. Lam, B. Yamasaki, C. Sugahara, R. Li, M. Tanaka, Y. Liang, T. J. Tateno, C. Saito, T.
      JCI Insight. 2023 May 8;8(9):e162404. doi: 10.1172/jci.insight.162404.

      Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses

        Kobayashi, C. Watanabe, Y. Oshima, M. Hirose, T. Yamasaki, M. Iwamoto, M. Iwatsuki, M. Asami, Y. Kuramochi, K. Wakae, K. Aizaki, H. Muramatsu, M. Sureau, C. Sunazuka, T. Watashi, K.
        Viruses. 2022 Apr 6;14(4). pii: v14040764. doi: 10.339/v14040764.

        Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse Model

          Ye, X. Tateno, C. Thi, E. P. Kakuni, M. Snead, N. M. Ishida, Y. Barnard, T. R. Sofia, M. Shimada, T. Lee, A. C. H.

          ACS Infect Dis. 2018 Nov 8. doi: 10.1021/acsinfecdis.8b00192.

          A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide

            Kaneko, M. Watashi, K. Kamisuki, S. Matsunaga, H. Iwamoto, M. Kawai, F. Ohashi, H. Tsukuda, S. Shimura, S. Suzuki, R. Aizaki, H. Sugiyama, M. Park, S. Y. Ito, T. Ohtani, N. Sugawara, F. Tanaka, Y. Mizokami, M. Sureau, C. Wakita, T.

            J Virol. 2015 Dec;89(23):11945-53. doi: 10.1128/JVI.01855-15.